Excerpts from DuPont's Analyst Day - Analyst Blog
May 03 2013 - 11:50AM
Zacks
Chemical titan
DuPont (DD) divulged its strategic and operational
priorities for this year and beyond during its annual investor day
in Wilmington, Del. Chairman and CEO Ellen Kullman highlighted
three strategic priorities that are aimed at boosting shareholder
value and driving multi-year sales and earnings.
Kullman noted that DuPont’s priorities are expansion of its leading
footprint across the food value chain, reinforcing its leadership
position as a provider of differentiated, high-value advanced
materials, and development of leading industrial biotechnology
capabilities. Boosting R&D returns will be a top priority.
DuPont reaffirmed, at the meet, its compound annual growth rate
(CAGR) targets for sales and operating earnings per share of 7% and
12%, respectively. The company said that it is optimistic in
achieving these long-term goals given its portfolio strength,
scientific capabilities, global reach and strong execution. Prudent
cost saving measures and new products will also help in achieving
these targets.
DuPont has embarked on an aggressive cost-cutting strategy by
reducing fixed costs, retrenching employees, restructuring work
schedules and improving working capital productivity. The company
expects pre-tax cost savings of at least $300 million from its
restructuring measures in 2013. DuPont also has a bevy of new
products in its pipeline that are expected to create value for its
customers.
Nicholas C. Fanandakis, DuPont’s Vice President and Chief Financial
Officer, presented long-term profit margin targets for each
business segment at the meet. For the agriculture business, the
company expects margins of as much as 24% and sales CAGR of up to
10%.
DuPont is witnessing strong momentum in its agriculture business
and is seeing healthy demand for its corn hybrids. Strong planting
activity by growers across North and Latin America, product
innovation, solid order book and healthy supply of seeds and crop
protection products strongly positions DuPont in the agriculture
market.
For both electronics and industrial
biosciences franchises, long-term margins are expected to be as
high as 18% while sales CAGR target has been pegged at up to
9%.
In electronics, DuPont expects to benefit from higher adoption of
the organic light emitting diodes (OLED) technology for TVs and is
well placed to capture incremental opportunities in consumer
electronics and photovoltaic markets. For industrial bioscience,
higher demand for enzymes in emerging geographies and increasing
use of sustainable materials represents the driving factors.
The nutrition and health unit is expected to see margins and sales
CAGR of as much as 14% and 9%, respectively. The rapidly growing
specialty food ingredients market has been seen as an attractive
opportunity.
For the performance chemical business, DuPont foresees margins and
sales CAGR of as much as 20% and 5%, respectively. The division
remains challenged by weak titanium dioxide market fundamentals.
Lower pricing for titanium dioxide, which is used to give paint and
other coatings a white hue, is hurting performance chemical
results. Nevertheless, key growth drivers include expansion of
Altamira pigment plant in Mexico and roll out of next-generation
refrigerants.
DuPont’s performance materials business is expected to see profit
margins of as much as 18% and sales CAGR of up to 5%. Healthy
trends are being witnessed across packaging and light-weighting
automotive.
Lastly, margins and sales CAGR for safety and protection has been
set at as much as 23% and 7%, respectively. Increased
infrastructure investments and product innovation are among key
drivers for growth.
DuPont carries a Zacks Rank #3 (Hold).
Other companies in the chemical industry that are worth considering
include Shin-Etsu Chemical Co., Ltd. (SHECY),
Celanese Corporation (CE) and Methanex
Corporation (MEOH). While Shin-Etsu Chemical retains a
Zacks Rank #1 (Strong Buy), both Celanese and Methanex hold a Zacks
Rank #2 (Buy).
CELANESE CP-A (CE): Free Stock Analysis Report
DU PONT (EI) DE (DD): Free Stock Analysis Report
METHANEX CORP (MEOH): Free Stock Analysis Report
SHIN-ETSU CHEM (SHECY): Get Free Report
To read this article on Zacks.com click here.
Zacks Investment Research
Shin Etsu Chemical (PK) (USOTC:SHECY)
Historical Stock Chart
From Nov 2024 to Dec 2024
Shin Etsu Chemical (PK) (USOTC:SHECY)
Historical Stock Chart
From Dec 2023 to Dec 2024